Literature DB >> 20831288

Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future.

Kalipso Chalkidou1, Tom Walley.   

Abstract

Health systems that have fixed budgets and a coherent organizational structure generally have found it valuable to have a dedicated primary research capacity to answer decision-oriented value-for-money questions of particular importance to the system. The UK NHS is one example of such a system. Here, we review the historical evolution of building comparative effectiveness research (CER) capacity in the NHS, describe the current situation, with a focus on how this research is used to inform decisions, and discuss present and emerging challenges. We draw some possible lessons for the US, which is currently considering using CER to inform healthcare policy and practice decisions.

Mesh:

Year:  2010        PMID: 20831288     DOI: 10.2165/11535260-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  32 in total

1.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

2.  5 NICE years.

Authors:  Michael D Rawlins
Journal:  Lancet       Date:  2005 Mar 5-11       Impact factor: 79.321

3.  Health research in the UK: the price of success.

Authors:  Richard Horton
Journal:  Lancet       Date:  2006-07-08       Impact factor: 79.321

4.  Paying for promising but unproven technologies.

Authors:  Douglas Kamerow
Journal:  BMJ       Date:  2007-11-10

5.  Health technology assessment in England: assessment and appraisal.

Authors:  Tom Walley
Journal:  Med J Aust       Date:  2007-09-03       Impact factor: 7.738

6.  A model for NICE in the US.

Authors:  R E Ferner; Sarah E McDowell
Journal:  BMJ       Date:  2009-06-03

7.  Comparative effectiveness research and evidence-based health policy: experience from four countries.

Authors:  Kalipso Chalkidou; Sean Tunis; Ruth Lopert; Lise Rochaix; Peter T Sawicki; Mona Nasser; Bertrand Xerri
Journal:  Milbank Q       Date:  2009-06       Impact factor: 4.911

Review 8.  The role of the Veterans Affairs Medical Centers in patient care, surgical education, research and faculty development.

Authors:  Walter E Longo; William Cheadle; Aaron Fink; Robert Kozol; Ralph DePalma; Robert Rege; Leigh Neumayer; John Tarpley; Margaret Tarpley; Ray Joehl; Thomas A Miller; Douglas Rosendale; Kamal Itani
Journal:  Am J Surg       Date:  2005-11       Impact factor: 2.565

9.  Redefining competition in health care.

Authors:  Michael E Porter; Elizabeth Olmsted Teisberg
Journal:  Harv Bus Rev       Date:  2004-06

10.  Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

Authors:  Jo C Dumville; Gill Worthy; J Martin Bland; Nicky Cullum; Christopher Dowson; Cynthia Iglesias; Joanne L Mitchell; E Andrea Nelson; Marta O Soares; David J Torgerson
Journal:  BMJ       Date:  2009-03-19
View more
  5 in total

1.  Translating comparative effectiveness research into clinical practice: the UK experience.

Authors:  Tom Walley
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

2.  Perspectives on comparative effectiveness research: views from diverse constituencies.

Authors:  Dave Nellesen; Howard G Birnbaum; Paul E Greenberg
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  A framework for describing health care delivery organizations and systems.

Authors:  Ileana L Piña; Perry D Cohen; David B Larson; Lucy N Marion; Marion R Sills; Leif I Solberg; Judy Zerzan
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

Review 4.  Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.

Authors:  Joel P Thompson; Amir Abdolahi; Katia Noyes
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

5.  What values do the public want their health care systems to use in evaluating technologies?

Authors:  Martin J Buxton; James D Chambers
Journal:  Eur J Health Econ       Date:  2011-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.